Wed, January 3, 2018
Tue, January 2, 2018
Tue, December 26, 2017
Fri, December 22, 2017
Thu, December 21, 2017
Wed, December 20, 2017
Tue, December 19, 2017
Mon, December 18, 2017

Mark Breidenbach Initiated (BLUE) at Hold on, Dec 21st, 2017

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ach-initiated-blue-at-hold-on-dec-21st-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Mark Breidenbach of Oppenheimer, Initiated "bluebird bio, Inc." (BLUE) at Hold on, Dec 21st, 2017.

Mark has made no other calls on BLUE in the last 4 months.



There are 8 other peers that have a rating on BLUE. Out of the 8 peers that are also analyzing BLUE, 3 agree with Mark's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jason McCarthy of "Maxim Group" Downgraded from Strong Buy to Hold on, Wednesday, December 13th, 2017
  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, November 6th, 2017
  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, November 3rd, 2017


These are the ratings of the 5 analyists that currently disagree with Mark


  • Biren Amin of "Jefferies" Upgraded from Hold to Strong Buy on, Monday, December 11th, 2017
  • John Newman of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $202 on, Tuesday, December 5th, 2017
  • Dane Leone of "BTIG" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $162 on, Thursday, November 2nd, 2017
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $162 on, Monday, October 30th, 2017